InsiderClue
Insiders · Profile

Bodenstedt Matthias

Chief Financial Officer at MoonLake Immunotherapeutics. Filing since 19 Dec 2023. CIK 0001920545

Company
Date
Role
Action
Shares
Amount
Of holding
MLTX MoonLake Immunotherapeutics
22 Jun 2026
Chief Financial Officer
Sold on a plan
39,120
$862.20K
3.4%
MLTX MoonLake Immunotherapeutics
18 Jun 2026
Chief Financial Officer
Sold on a plan
2,794
$54.76K
0.2%
MLTX MoonLake Immunotherapeutics
17 Jun 2026
Chief Financial Officer
Sold on a plan
15,082
$296.81K
1.3%
MLTX MoonLake Immunotherapeutics
11 May 2026
Chief Financial Officer
Sold on a plan
13,653
$273.33K
1.2%
MLTX MoonLake Immunotherapeutics
14 Apr 2026
Chief Financial Officer
Sold on a plan
2,426
$47.45K
0.2%
MLTX MoonLake Immunotherapeutics
10 Apr 2026
Chief Financial Officer
Sold on a plan
1,925
$37.56K
0.2%
MLTX MoonLake Immunotherapeutics
9 Apr 2026
Chief Financial Officer
Sold on a plan
85,870
$1.63M
6.7%
MLTX MoonLake Immunotherapeutics
8 Oct 2025
Chief Financial Officer
Bought
10,870
$98.81K
1.8%
MLTX MoonLake Immunotherapeutics
20 Dec 2023
Chief Financial Officer
Sold on a plan
5,264
$307.10K
1.0%
MLTX MoonLake Immunotherapeutics
19 Dec 2023
Chief Financial Officer
Sold on a plan
94,736
$5.61M
15.3%
10 decisions on file.